JPS5726625A - Sustained release type composite material entrapping medical enzyme and its preparation - Google Patents

Sustained release type composite material entrapping medical enzyme and its preparation

Info

Publication number
JPS5726625A
JPS5726625A JP10146380A JP10146380A JPS5726625A JP S5726625 A JPS5726625 A JP S5726625A JP 10146380 A JP10146380 A JP 10146380A JP 10146380 A JP10146380 A JP 10146380A JP S5726625 A JPS5726625 A JP S5726625A
Authority
JP
Japan
Prior art keywords
composite material
medical
protein
sustained release
type composite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10146380A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0217527B2 (cs
Inventor
Isao Kaetsu
Masaru Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Atomic Energy Agency
Original Assignee
Japan Atomic Energy Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Atomic Energy Research Institute filed Critical Japan Atomic Energy Research Institute
Priority to JP10146380A priority Critical patent/JPS5726625A/ja
Publication of JPS5726625A publication Critical patent/JPS5726625A/ja
Publication of JPH0217527B2 publication Critical patent/JPH0217527B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP10146380A 1980-07-24 1980-07-24 Sustained release type composite material entrapping medical enzyme and its preparation Granted JPS5726625A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10146380A JPS5726625A (en) 1980-07-24 1980-07-24 Sustained release type composite material entrapping medical enzyme and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10146380A JPS5726625A (en) 1980-07-24 1980-07-24 Sustained release type composite material entrapping medical enzyme and its preparation

Publications (2)

Publication Number Publication Date
JPS5726625A true JPS5726625A (en) 1982-02-12
JPH0217527B2 JPH0217527B2 (cs) 1990-04-20

Family

ID=14301395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10146380A Granted JPS5726625A (en) 1980-07-24 1980-07-24 Sustained release type composite material entrapping medical enzyme and its preparation

Country Status (1)

Country Link
JP (1) JPS5726625A (cs)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
US5597802A (en) * 1990-06-07 1997-01-28 Genentech, Inc. Method of formulating IGF-I with growth hormone
FR2810336A1 (fr) * 2000-06-19 2001-12-21 Prod Oenologiques J Laffort & Procede de fabrication d'un produit de clarification ajustee d'un vin et produit de clarification obtenu

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5247912A (en) * 1975-10-09 1977-04-16 Minnesota Mining & Mfg Solid serum albumin circles and its production

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5247912A (en) * 1975-10-09 1977-04-16 Minnesota Mining & Mfg Solid serum albumin circles and its production

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597802A (en) * 1990-06-07 1997-01-28 Genentech, Inc. Method of formulating IGF-I with growth hormone
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
FR2810336A1 (fr) * 2000-06-19 2001-12-21 Prod Oenologiques J Laffort & Procede de fabrication d'un produit de clarification ajustee d'un vin et produit de clarification obtenu
EP1167513A1 (fr) * 2000-06-19 2002-01-02 Produits Oenologiques J. Laffort & Cie (Société Anonyme) Procédé de fabrication d'un produit de clarification ou de collage et produit obtenu

Also Published As

Publication number Publication date
JPH0217527B2 (cs) 1990-04-20

Similar Documents

Publication Publication Date Title
Seaman et al. The surface structure of erythrocytes from some animal sources
ATE94553T1 (de) Verfahren zur isolierung von langkettiger nukleinsaeure.
ES2185218T5 (es) Un plasma sanguineo aplicable universalmente.
NL190268C (nl) Werkwijze voor het bereiden van een bloedstollingsbevorderend preparaat op basis van humane proteinen.
ES8106407A1 (es) Procedimiento para el tratamiento de superficies hidrofobas
JPS56135418A (en) Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
ATE287210T1 (de) Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen
DE3680368D1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
HRP931496A2 (en) Process for the preparation of biological preparations not containing (active) viruses
Morgenstern Coated membranes in blood platelets
US4537852A (en) Process for the production of human urokinase
JPS5726625A (en) Sustained release type composite material entrapping medical enzyme and its preparation
EP0152072A3 (en) Pulsed light selective photolysis process for treatment of biological media and products made thereby
IT8148915A1 (it) Procedimento per la produzione di insulina umana
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
AU678343B2 (en) Method and composition for determining the immunological activity of bioactive substances
JPS56115713A (en) Preparation of slow-releasing complex
JPS579709A (en) Preparation of prolonged release type complex
WO1991006322A1 (en) Magnetocontrollable carrier with physiologically active substance and method for making said carrier
JPS57144983A (en) Preparation of physiologically active substance
US4624917A (en) Process for the production of human T-cell growth factor
Dalrymple et al. Radiation produces breaks in L cell and mouse liver DNA characterized by 5′ phosphoryl termini
Werner et al. Purification of proteins produced by biotechnological process
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
Chang Artificial cell including blood substitute and biomicroencapsulation: from ideas to applications